PointsBet Holdings Limited (ASX:PBH) Announces H1 FY25 Results
PointsBet Holdings Limited (ASX:PBH) reports a 6% revenue increase in H1 FY25 and announces its acquisition by MIXI.
Tag: Corporate Strategy & Guidance
NZME Limited (ASX:NZM) Announces 2024 Full Year Results
NZME Limited (ASX:NZM) reports a 2% increase in operating revenue for 2024, highlighting significant digital growth and strategic initiatives.
Steadfast Group (ASX:SDF) Announces 1H25 Results
Steadfast Group (ASX:SDF) reports a 20.9% NPAT increase and a 15.6% interim dividend rise for 1H25.
Acrux (ASX:ACR) Reports A$20M Revenue and Announces US Product Launches
Acrux (ASX:ACR) reports A$20 million revenue for FY23-FY24 and announces new US product launches, bolstering its presence in the pharmaceutical market.
4DMedical Limited (ASX:4DX) Launches Share Purchase Plan
4DMedical Limited (ASX:4DX) launches a Share Purchase Plan, enabling shareholders to buy up to $30,000 in new shares without fees.
Telix Pharmaceuticals Limited (ASX:TLX) Changes Reporting Currency to USD
Telix Pharmaceuticals Limited (ASX:TLX) will change its reporting currency from AUD to USD effective 1 January 2025, aligning financial reports with its US-based operations.
Viva Energy (ASX:VEA) Announces FY2024 Financial Results
Viva Energy (ASX:VEA) reports a 5% EBITDA increase in FY2024, driven by strategic acquisitions and strong operational performance.
AuMEGA Metals (ASX:AAM) Commences Winter Drill Program at Bunker Hill
AuMEGA Metals (ASX:AAM) commences its 2025 winter drill program at Bunker Hill, targeting high-grade copper, silver, and gold resources.
A1 Investments & Resources Ltd (ASX:AYI) Reports H1 Financial Results
A1 Investments & Resources Ltd (ASX:AYI) reports a significant decline in revenue and reduced losses for the half-year ended December 2023, with no dividends declared.
Noxopharm Limited (ASX:NOX) Reports FY2025 Half Year Results
Noxopharm Limited (ASX:NOX) reports a 50.5% reduction in half-year losses and advances its clinical trials and strategic partnerships.